INS and metabolic dysfunction-associated steatotic liver disease: Extensive animal and cellular experiments demonstrate that BPA promotes hepatic lipid droplet accumulation and accelerates MASLD onset and progression by disrupting lipid metabolism, inducing insulin resistance, triggering oxidative stress, and interfering with hepatocellular mitochondrial function.19